Navigation Links
Pfizer Commences Tender Offer for All Outstanding Shares of King Pharmaceuticals, Inc.
Date:10/22/2010

NEW YORK, Oct. 22 /PRNewswire-FirstCall/ -- Pfizer Inc. (NYSE: PFE) today announced the commencement of a tender offer by its wholly owned subsidiary, Parker Tennessee Corp., for all outstanding shares of common stock of King Pharmaceuticals, Inc. (NYSE: KG) for $14.25 per share, net to the seller in cash, without interest thereon and subject to any required withholding taxes.  The tender offer is being made pursuant to an Offer to Purchase, dated October 22, 2010, and in connection with the previously announced Agreement and Plan of Merger, dated October 11, 2010, by and among Pfizer, Parker Tennessee Corp. and King.  

(Photo:  http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO )

(Photo:  http://www.newscom.com/cgi-bin/prnh/20100416/PFIZERLOGO )

Today, Pfizer and Parker Tennessee Corp. will file with the U.S. Securities and Exchange Commission (the "SEC") a Tender Offer Statement on Schedule TO, containing the Offer to Purchase, form of Letter of Transmittal and related tender offer documents, which set forth in detail the terms and conditions of the tender offer.  King will file with the SEC a Solicitation/Recommendation Statement on Schedule 14D-9 setting forth in detail, among other things, the unanimous recommendation of King's Board of Directors that King's shareholders accept the tender offer, tender their shares pursuant to the tender offer and, if required by applicable law, approve the Agreement and Plan of Merger and the transactions contemplated thereby.  These documents will be mailed to all King shareholders of record.

The tender offer is scheduled to expire at 12:00 midnight, New York City
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pfizer Enters Into Agreement to Acquire 40 Percent Stake in Teuto in Brazil
2. Biocon and Pfizer Enter Into Global Commercialization Agreement
3. Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets
4. Pfizer Completed Acquisition of FoldRx
5. Pfizer To Review Strategic Alternatives For Capsugel
6. Pfizer Offers First 500,000 Consumers Free Advil® to Launch Medicine Cabinet Cleanout Campaign
7. Pfizer Invites Public to View and Listen to Webcast of November 2 Conference Call With Analysts
8. Pfizer Discontinues Phase 3 Trial of SUTENT® in Advanced Castration-Resistant Prostate Cancer
9. Updated Pfizer Pipeline Focuses on Value, Unmet Medical Need
10. Reportlinker Adds Pfizer Inc.: PharmaVitae Profile
11. Amgen and Pfizer Introduce Psophisticated Style: A Guide to Everyday Style and Psoriasis™ Hosted by Tim Gunn
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... June 30, 2015  Today, the National Mobility Equipment ... 2015 National Mobility Awareness Month Local Heroes Contest on ... online entries that received 1.3 million votes. The sponsors ... Toyota Mobility , and Valley Honda Dealers ... and Vantage Mobility International (VMI) and ...
(Date:6/30/2015)... Calif. , June 30, 2015  Avanir ... PRISM II study showing that treatment with NUEDEXTA ... reduction in symptoms of pseudobulbar affect (PBA) in ... PBA is a distressing condition characterized by sudden ... from certain neurologic diseases or brain injury. PRISM ...
(Date:6/30/2015)... Minn. , June 30, 2015  EnteroMedics Inc. ... devices that use neuroblocking technology to treat obesity, metabolic ... its previously announced public offering  of 40,229,886 units. Each ... of a Series A warrant to purchase one share ... warrant to purchase one share of common stock, at ...
Breaking Medicine Technology:NMEDA Announces National Contest Winners 2NMEDA Announces National Contest Winners 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3
(Date:6/30/2015)... Arlington, Texas (PRWEB) , ... June 30, 2015 , ... ... at some point in life. Back pain can range from a dull, constant ache ... back pain such as epidural steroid injections, selective nerve root blocks and ...
(Date:6/30/2015)... CA (PRWEB) , ... June 30, 2015 , ... It ... the florets once in the kitchen, and discard the stalks before cooking. Throwing out ... actually can be eaten and are quite delicious. It just takes a little knowledge ...
(Date:6/30/2015)... ... ... New Xarelto lawsuit claims proposed for consolidation in the ... to attorneys handling Xarelto lawsuits included in the MDL.* The forms, ... plaintiffs’ attorneys in filing new claims, according to court documents. Drafts of these ...
(Date:6/30/2015)... BC (PRWEB) , ... June 30, 2015 , ... When ... might be that they feel the associated costs will be too high. However, there ... have the volunteer abroad experience at minimal cost. One such volunteer named ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... and operated service and repair companies in San Diego. Bill Howe offers all ... the company, through several organizations, but most notably through the local Plumbing-Heating-Cooling-Contractors of ...
Breaking Medicine News(10 mins):Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 3Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 2Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 3Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 4Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 2Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 3Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 2Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 3Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 2Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 3
... alert in India's northeast asking authorities to take ... outbreak in Bangladesh and Myanmar, officials said ... Tripura government has made arrangements for free consultation ... sub-divisions, especially those along the bordering areas," Tripura's ...
... known as a poison that can kill, arsenic also can ... leukemia , a new study out Saturday found. ... we give (arsenic) earlier in the course of treatment," said ... in North Carolina, and the lead author of the research ...
... issue of JAMA, has identified novel genetic mutations linked ... these mutations are due to both independent mutational events ... to coincide with its presentation at the annual meeting ... ,According to background information in the article, gastric cancer ...
... CHICAGO, According to a University of Pittsburgh Medical Center ... American Society of Clinical Oncology (ASCO) in Chicago and ... patients treated for follicular lymphoma, a slow-growing type of ... ,Over 90 percent of study patients responded ...
... CEGE) today announced follow-up data from a Phase 2 ... was conducted by the Johns Hopkins Sidney Kimmel Cancer ... pancreatic cancer who received GVAX after surgical resection of ... overall survival for these patients was previously reported to ...
... receiving end, even if it is all subtle, as in ... to pin down is more dangerous to mental health ... immigrants living in Canada. ,"We found that the ... distress such as symptoms of depression and anxiety," said lead ...
Cached Medicine News:Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 2Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 3Health News:Lymphoma Patients Maybe Helped by Adding Radioimmunotherapy to Chemo 2Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 2Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 3Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 4Health News:Koreans in Canada Feel Put Down by Subtle Racism 2